Published in PLoS One on February 03, 2015
Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. J Diabetes Res (2015) 0.79
Effects of developmental iron deficiency and post-weaning iron repletion on the levels of iron transporter proteins in rats. Nutr Res Pract (2015) 0.77
Correction: High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload. PLoS One (2015) 0.75
Iron and non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
Iron Supplementation Reverses the Reduction of Hydroxymethylcytosine in Hepatic DNA Associated With Chronic Alcohol Consumption in Rats. J Cancer Prev (2016) 0.75
Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int J Mol Sci (2017) 0.75
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. Int J Mol Sci (2017) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol (1962) 3.31
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2011) 2.97
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Iron metabolism and toxicity. Toxicol Appl Pharmacol (2005) 2.17
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology (2009) 2.07
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology (2002) 2.04
Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care (2004) 1.90
Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest (2012) 1.78
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol (2006) 1.70
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol (2010) 1.68
Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem (1995) 1.65
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol (2011) 1.59
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol (2007) 1.41
Macrophages and systemic iron homeostasis. J Innate Immun (2012) 1.40
Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care (1998) 1.39
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr (2008) 1.25
Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res (2005) 1.14
Iron regulatory proteins in pathobiology. Biochem J (2000) 1.12
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis (2010) 1.08
Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology (2008) 1.07
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology (2005) 1.06
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol (2010) 1.05
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS One (2012) 1.05
High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem (2012) 1.02
Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood (2010) 0.99
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J Hepatol (2008) 0.97
High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. PLoS One (2013) 0.96
Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst (2008) 0.96
Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol (2008) 0.90
Molecular mechanisms regulating hepcidin revealed by hepcidin disorders. ScientificWorldJournal (2011) 0.88
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am J Pathol (2009) 0.88
The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease. PLoS One (2012) 0.88
Ferritin couples iron and fatty acid metabolism. FASEB J (2012) 0.83
Dietary fat level affects tissue iron levels but not the iron regulatory gene HAMP in rats. Nutr Res (2012) 0.82